RBC Capital Maintains Outperform on Autoliv, Lowers Price Target to $146
RBC Capital analyst Tom Narayan maintains Autoliv (NYSE:ALV) with a Outperform and lowers the price target from $147 to $146.
Stocks · News reference
Jefferies analyst Vanessa Jeffriess maintains Autoliv (NYSE:ALV) with a Hold and lowers the price target from $134 to $119.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
RBC Capital analyst Tom Narayan maintains Autoliv (NYSE:ALV) with a Outperform and lowers the price target from $147 to $146.
Analysts downgraded Accelerant, Autoliv, Compass Therapeutics, Wave Life Sciences and PG&E; price targets for CMPX and PCG were cut.